Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Research Recap | The Growing Appetite for Obesity Drugs

    Research Recap | The Growing Appetite for Obesity Drugs

    FromMaking Sense

    Start listeningView podcast show

    Research Recap | The Growing Appetite for Obesity Drugs

    FromMaking Sense

    ratings:
    Length:
    25 minutes
    Released:
    Dec 1, 2023
    Format:
    Podcast episode

    Description

    The market for GLP-1s — also commonly known as obesity drugs — is projected to exceed $100 bn globally by 2030. Why are these drugs growing in popularity, and could they lead to a paradigm shift in health care? Elif Korkmaz, who covers Health Care Specialist Sales, sits down with Chris Schott, Senior Analyst covering U.S. Diversified Biopharma, and Richard Vosser, Head of European Pharma & Biotech, to discuss the latest developments in this space.
    This episode was recorded on Wednesday, November 29th.
    This communication is provided for information purposes only. Please read JP Morgan research reports related to its contents for more information including important disclosures.
    Copyright 2023 JP Morgan Chase & Co. All rights reserved.
    Released:
    Dec 1, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    “Making Sense,” the podcast channel from J.P. Morgan’s Corporate & Investment Bank, brings you views and analysis from the Investment Banking, Markets and Research businesses. In each episode, experts discuss the latest market outlooks, trends and developments impacting our complex global economy. Subscribe now for insights that will help you navigate the world we live in.